| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Scientific Officer
2 companies
Sepp-Lorenzino Laura is a Director at TSHA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sell | 8,966 | $12.18 | $109,205.88 | -10.4% | -43.2% | -24.1% | |
| Jan 8, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sell | 2,275 | $28.87 | $65,681.74 | -2.5% | -15.9% | -58.5% | |
| Jan 3, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sell | 5,532 | $29.46 | $162,972.72 | -10.7% | -14.9% | -58.6% | |
| Jan 5, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sell | 4,838 | $37.82 | $182,981.60 | -8.0% | -7.7% | -26.2% | |
| Jan 1, 2022 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sale+OE | 1,148 | $112.25 | $128,863.00 | -19.3% | -35.6% | -70.7% | |
| Aug 30, 2021 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sale+OE | 97,000 | $154.83 | $15,018,054.43 | -30.0% | -27.4% | -60.9% | |
| Aug 4, 2021 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Scientific Officer | Sale+OE | 26,000 | $138.24 | $3,594,356.93 | -24.2% | -7.7% | -55.5% |